On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayMar 07, 2022 11:00 am

Cepton Inc.’s (NASDAQ: CPTN) Management Rings Nasdaq Opening Bell After Commencing Formal Trade on the Exchange

Cepton, Inc formally listed on the Nasdaq Capital Market on February 11, 2022, following the merger between Cepton Technologies Inc., and SPAC, Growth Capital Acquisition Corp (GCAC) Cepton’s CEO, Dr. Jun Pei rang the Nasdaq opening bell on Thursday, February 17, alongside CTO Dr. Mark McCord and members of both, Cepton Technologies and Growth Capital Acquisition Corp GCAC and Cepton arrived at a formal combination agreement on August 5, 2021, with the transaction valuing Cepton at an enterprise value of $1.5 billion Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMR(R) lidar solutions, held the opening bell…

Continue Reading

FridayMar 04, 2022 9:30 am

Investor Summit Q1 Conference – featuring C Level Management of 65 + Companies

Companies and investors are invited to attend the Q1 2022 Virtual Investor Summit being held as a virtual event on March 8-9th, 2022.  The Investor Summit has been the largest independent conference on the East Coast for many years (formerly "The Microcap Conference") and represents companies that are looking for a timely platform to connect with investors. The Q1 investor Summit focuses on connecting small and microcap companies with potential investors from large institutions, family businesses, private wealth and money managers. This Q1 conference will offer C level executives the opportunity to make presentations about the state of their business,…

Continue Reading

FridayMar 04, 2022 9:30 am

34th Annual ROTH Conference To Be Held As An In-person Event In California

The Roth Capital Partners invites small-cap companies, entrepreneurs, industries, and businesses to attend the 34th Annual ROTH Conference being held on March 13-15, 2022 at The Ritz Carlton, Laguna Niguel, Dana Point, California. Respected heads and leaders of leading companies from a spectrum of diverse sectors, including consumer, energy, healthcare, industrial growth, metals & mining, sustainability, services, technology, and more, will be gracing the occasion. Roth is a privately-owned investment banking firm dedicated to offering growth and networking opportunities to the small-cap public market. With previous years showing some exciting feedback and responses from participants, sponsors and presenting companies, Roth Conferences are now…

Continue Reading

FridayMar 04, 2022 9:15 am

SRAX Inc. (NASDAQ: SRAX) Foresee Surging Revenue as Millennials are All-In on Corporate Transparency

SaaS company SRAX offers a robust suite of cutting-edge products that facilitate engagement between public companies and investors, both existing and potential SRAX forecasts a record first quarter of $11.5 million in revenue as part of 2022 revenue in the range of $46-$48 million The company bought back ~$800,000 during Q2 2021, paid a dividend in January, and optimized its cap table via the elimination of an ATM filing There are common fundamental threads between investing 30 years ago and today, but many things are extremely different. The digital age has changed everything, and fintech companies like SRAX (NASDAQ: SRAX)…

Continue Reading

FridayMar 04, 2022 9:15 am

Studies Advance Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Technology for Significantly Improving Pharmaceutical Drugs

Lexaria Bioscience is dedicated to applying its patented technology to pharmaceutical drug offerings to enhance their performance and speed their rate of effective use The company’s flagship DehydraTECH(TM) technology has delivered numerous successes in studies of its potential for treating high blood pressure and heart disease, nicotine addiction, and virus infection Most recently, the company reported successes in increasing the speed and effectiveness in a drug treating erectile dysfunction (“ED”) in laboratory animals Lexaria is preparing an investigational new drug (“IND”) application for its hypertension line of study with the aim of achieving a new drug application (“NDA”) approval from…

Continue Reading

FridayMar 04, 2022 9:00 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Adds Indonesia Node as Lightning Network Reaches All-Time High

Bitcoin locked on the Lightning Network has an estimated value of US$1.3 billion – indicating a bullish market contrary to the Bitcoin bear market LQwD has nodes active on the Lightning Network in the U.S., Germany, Singapore, and Indonesia, growing at an exponential rate by the day The Bitcoin Payment Ecosystem is expected to reach US$880 million by 2026 LQwD launched its PaaS offering in November, aiming to facilitate payments worldwide   Bitcoin reached an all-time high of US$61,374.28 in October 2021, but since then the cryptocurrency’s value fluctuated significantly, dropping to US$37,928.58 in January 2022 (https://ibn.fm/OMawU). Throughout February, Bitcoin value…

Continue Reading

ThursdayMar 03, 2022 9:30 am

StraightUp Resources Inc. (CSE: ST) (OTCQB: STUPF) Keeping a Close Eye on the Evolving Geopolitical Situation, and its Impact on Risk-Taking

The price of gold has increased by 6.5% to reach an 18-month high of $1,973.96 Palladium has also increased by 5.1% in value for the third consecutive month Gold is proving to be the main safe-haven asset with the growing tensions StraightUp acknowledges a change in shareholders’ willingness to take more risks but looks to capitalize on opportunities that present themselves, specifically with the increase in the price of gold Back in 2020, organizations worldwide had to deal with the pandemic and the geopolitical risk it presented. At that time, the situation affected investment and, more importantly, investors’ risk-taking appetite,…

Continue Reading

ThursdayMar 03, 2022 9:15 am

Friendable Inc. (FDBL) Creates “Anti-Label” Movement with Fan Pass Live Artist Platform and Newly Acquired Artist Republik

Fan Pass Live was released by Friendable in July 2020, and Artist Republik’s acquisition was completed in January 2022 Friendable is positioned to leverage two markets – music streaming and music distribution services, capitalizing on technological advancements and the shift to digital platforms The global music streaming market was valued at $24.4 billion in 2020 and is expected to reach $76.9 billion by 2027 The global music distribution services market was valued at $911.87 million in 2020 and is expected to reach $1.7 billion by 2030 In a movement of true independence for recording artists, Friendable (OTC: FDBL) is making…

Continue Reading

ThursdayMar 03, 2022 9:15 am

Knightscope, Inc. (NASDAQ: KSCP) Ramps Up Investor Relations Efforts with Dedicated Investor Deck as It Continues its Journey Toward Making the U.S. the Safest Country Globally Through the Application of Advanced Robotics Technology

Knightscope’s shares began trading publicly on the Nasdaq Global Market on January 27, following the closing of a public offering that kicked off in early December Following the public offering, Knightscope has entered its 2nd chapter as it continues to work toward making the U.S. the safest nation in the world The company has now created a dedicated investor deck to help inform prospective and existing Knightscope investors Roughly 90% of women and 60% of men visit companies’ investor relations (“IR”) websites when researching a new investment opportunity. These statistics, uncovered by PR Newswire’s Vintage Division in its 2016 Shareholder…

Continue Reading

ThursdayMar 03, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Granted U.S. Patent for Deuterated DMT

Company announced the first officially issued patent Patent provides strong protection for Cybin’s growing IP portfolio of psychedelic-based compounds CYB004 has demonstrated potential efficacy at lower doses while increasing duration of drug effect that may alleviate common negative experiences In a milestone moment for psychedelic therapeutics company Cybin (NEO: CYBN) (NYSE American: CYBN), the company has announced its first official issued patent. The U.S. Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,242,318 to Cybin’s proprietary CYB004, the company’s lead investigational proprietary DMT compound. “From the outset, Cybin has focused on creating differentiated compounds that harness the potential efficacy of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered